Progressive retinal atrophy

University of California, Davis Student Receives SBB Research Group Foundation STEM Scholarship

Retrieved on: 
Wednesday, April 3, 2024
Learning, Genetics, UC, Ophthalmology, Research, University, Student, STEM, Genomics, Progressive retinal atrophy, University of California, Davis, Nursing

CHICAGO, April 3, 2024 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Meher Khan a recipient of its STEM scholarship. The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).

Key Points: 
  • CHICAGO, April 3, 2024 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Meher Khan a recipient of its STEM scholarship.
  • The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).
  • Meher Khan, a sophomore, studies Genetics and Genomics at the University of California, Davis.
  • We are proud to support that future," said Matt Aven, co-founder and board member of the SBB Research Group Foundation.

SparingVision Nominated for the Prix Galien MedStart'up in the Category “Best Collaboration Dedicated to the Developing or Underserved Populations Worldwide”

Retrieved on: 
Monday, October 21, 2019
Biotechnology, Optical, Surgery, General Health, Health, Genetics, Clinical trials, Other Health, Ophthalmology, Blindness, Channelopathies, RTT, Retinitis pigmentosa, Retinal degeneration, Medical specialties, Organ systems, Retinitis, Foundation Fighting Blindness, Progressive retinal atrophy

Organized by the Fondation Galien and Business France, the Prix Galien MedStart'Up rewards the most promising start-ups in the healthcare sector, created by international partnerships between French and North American innovators.

Key Points: 
  • Organized by the Fondation Galien and Business France, the Prix Galien MedStart'Up rewards the most promising start-ups in the healthcare sector, created by international partnerships between French and North American innovators.
  • The Fighting Blindness Foundation, created in 1971, is one of the largest foundations in the United States for degenerative retinal diseases.
  • SparingVision has been selected for its treatment that fights against the most common retinitis pigmentosa of hereditary retinal degeneration.
  • SparingVision is developing SPVN06, a gene-independent drug candidate to treat retinitis pigmentosa, the most common inherited retinal degeneration.

Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness launch an open access program for patients with inherited retinal disease in the United States

Retrieved on: 
Wednesday, October 2, 2019
Ophthalmology, Vision, Organ systems, Foundation Fighting Blindness, Retina, Blindness, Rare diseases, Progressive retinal atrophy, Retinoschisis

The new program is an expansion of the My Retina Tracker genetic testing program established in 2017, when the Foundation Fighting Blindness partnered with Blueprint Genetics and InformedDNA to launch the My Retina Tracker genetic testing study.

Key Points: 
  • The new program is an expansion of the My Retina Tracker genetic testing program established in 2017, when the Foundation Fighting Blindness partnered with Blueprint Genetics and InformedDNA to launch the My Retina Tracker genetic testing study.
  • Now, My Retina Tracker will become available to all US patients with a clinical diagnosis of an inherited retinal disease (IRD).
  • The My Retina Tracker genetic testing program is expanding to be an open access, no-cost program for patients with a clinical diagnosis of an inherited retinal disease.
  • Established in 1971, the Foundation Fighting Blindness is the worlds leading private funding source for retinal degenerative disease research.

New Data from Johnson & Johnson Vision Highlights the Need and Potential Standards for Evidence-Based Decision-Making in Myopia

Retrieved on: 
Monday, November 5, 2018
Vision, RTT, Ophthalmology, Blindness, Perception, Visual impairment, Glaucoma, Cataract, Retinal degeneration, Retina, Progressive retinal atrophy, National Eye Institute

It is the most common cause of vision impairment and is associated with increased prevalence of cataracts, glaucoma, retinal degeneration and blindness.

Key Points: 
  • It is the most common cause of vision impairment and is associated with increased prevalence of cataracts, glaucoma, retinal degeneration and blindness.
  • Johnson & Johnson Vision is focused on helping people see better, connect better and live better.
  • At Johnson & Johnson Vision, we have a bold ambition: to change the trajectory of eye health around the world.
  • Follow @JNJVision on Twitter and Johnson & Johnson Vision on LinkedIn .

New Data from Johnson & Johnson Vision Highlights the Need and Potential Standards for Evidence-Based Decision-Making in Myopia

Retrieved on: 
Monday, November 5, 2018
Vision, RTT, Ophthalmology, Blindness, Perception, Visual impairment, Glaucoma, Cataract, Retinal degeneration, Retina, Progressive retinal atrophy, National Eye Institute

It is the most common cause of vision impairment and is associated with increased prevalence of cataracts, glaucoma, retinal degeneration and blindness.

Key Points: 
  • It is the most common cause of vision impairment and is associated with increased prevalence of cataracts, glaucoma, retinal degeneration and blindness.
  • Johnson & Johnson Vision is focused on helping people see better, connect better and live better.
  • At Johnson & Johnson Vision, we have a bold ambition: to change the trajectory of eye health around the world.
  • Follow @JNJVision on Twitter and Johnson & Johnson Vision on LinkedIn .

Foundation Fighting Blindness Urges Congress to Pass 'Eye-Bonds' Legislation

Retrieved on: 
Thursday, July 19, 2018
Ophthalmology, RTT, Vision, Foundation Fighting Blindness, Perception, Visual impairment, Retina, Emerging technologies, Blindness, Choroideremia, Progressive retinal atrophy

The Foundation Fighting Blindness has been an unparalleled leader in supporting research on inherited retinal diseases for over 46 years.

Key Points: 
  • The Foundation Fighting Blindness has been an unparalleled leader in supporting research on inherited retinal diseases for over 46 years.
  • The Foundation Fighting Blindness was established in 1971.
  • It has since raised more than $725 million for research aimed at preventing, treating and curing blindness caused by retinal degenerative diseases.
  • The Foundation has launched a global patient registry, www.MyRetinaTracker.org , to build knowledge of retinal diseases and advance clinical research.